Antiplatelet Agents in Acute Coronary Syndrome: Interventions for Hospital and Community Pharmacists
This Continuing Education activity is supported by an educational grant from Merck, Sharp and Dohme Corp.
This activity is supported by an educational grant from Merck, Sharp and Dohme Corp.
Nicholas B. Norgard, PharmD, BCPS
Clinical Assistant Professor
University at Buffalo, School of Pharmacy & Pharmaceutical Sciences
NYS Center of Excellence, Bioinformatics & Life Sciences
Buffalo, New York
After completing this continuing education program, the participant will be able to:
- Explain practice guideline recommendations for antiplatelet agents in acute coronary syndrome (ACS).
- Identify appropriate antiplatelet agents for individual patients.
- Document interventions and pharmacist activities that improve quality of care and reduce readmissions in ACS.
- Examine patient counseling techniques that reduce nonadherence in patients with ACS
ambulatory care, consultant, and
Type of activity: Application
Release date: November 7, 2015
Expiration date: November 7, 2016
Estimated time to complete activity: 2.0 hours
Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.2 CEUs) under the ACPE universal activity number 0290-0000-15-144-H01-P. The activity is available for CE credit through November 7, 2016.